Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose Article

Maki, KC, Davidson, MH, Malik, KC et al. (1999). Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose . AMERICAN JOURNAL OF CARDIOLOGY, 84(10), 1198-1203. 10.1016/S0002-9149(99)00534-2

cited authors

  • Maki, KC; Davidson, MH; Malik, KC; Albrecht, HH; O'Mullane, J; Daggy, BP

abstract

  • Hydroxypropylmethylcellulose (HPMC) is a food gum having several structural and functional properties in common with hypocholesterolemic soluble fibers. The safety and cholesterol-lowering efficacy of HPMC, incorporated into a National Cholesterol Education Program Step I diet, was compared with placebo in patients with mild to moderate hypercholesterolemia. After an 8-week National Cholesterol Education Program Step I dietary lead-in phase, 160 patients with low-density lipoprotein (LDL) cholesterol between 130 and 200 mg/dl and triglycerides <300 mg/dl were randomized to placebo, 2.5, 5.0, or 7.5 g/day of HPMC for a 6-week treatment period. Patients returned to the clinic every 2 weeks for lipid measurements and safety assessments. HPMC significantly lowered total, LDL, and non-high-density lipoprotein (HDL) cholesterol. LDL cholesterol concentrations (average of weeks 4 and 6) decreased by 3.0% (4.9 mg/dl), 5.9% (10.3 mg/dl), 12.1% (20.4 mg/dl), and 11.7% (20.3 mg/dl) from baseline levels in the placebo and 2.5, 5.0, and 7.5 g/day HPMC treatment groups, respectively. Statistically significant (p <0.05) reductions in LDL cholesterol were observed in the 5.0 and 7.5 g/day HPMC groups compared with placebo and 2.5 g/day HPMC treatment groups. Total and non-HDL cholesterol responses paralleled those of LDL cholesterol. There were no significant differences between the treatment groups in HDL cholesterol or triglyceride responses, incidence of adverse experiences, or gastrointestinal-related adverse experiences. These results suggest that HPMC is a well-tolerated and effective adjunct to diet for lowering LDL cholesterol in patients with mild to moderate hypercholesterolemia. Copyright (C) 1999 Excerpta Medica Inc.

publication date

  • November 18, 1999

published in

Digital Object Identifier (DOI)

start page

  • 1198

end page

  • 1203

volume

  • 84

issue

  • 10